GeneTelligence ApS: Financial statements 2017
CVR: 37669741
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GeneTelligence ApS (CVR 37669741) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 98,900 and a net result of DKK -174,687. The profit margin was -176.6%. Equity in the 2017 report amounted to DKK 354,844. The solvency ratio was 55.9%.
- Revenue
- DKK 98,900
- Gross Profit
- DKK 31,110
- Profit/Loss
- DKK -174,687
- Equity
- DKK 354,844
- Total Assets
- DKK 635,231
Official annual report
Keep an eye on GeneTelligence ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 21, 2017, Lone Thomsen Fisker has joined the board of directors of GeneTelligence ApS.
As of December 21, 2017, Kim Stengaard Holmsted has joined the board of directors of GeneTelligence ApS.
As of December 21, 2017, Anders With Fogstrup has joined the board of directors of GeneTelligence ApS.
As of December 21, 2017, Henrik Bom Olesen has left the board of directors of GeneTelligence ApS.
As of December 21, 2017, Louise Ellekilde Fogstrup has stepped down as chairman of GeneTelligence ApS.
GeneTelligence ApS has published its interim report for the period May 6, 2016 – December 31, 2016.
About GeneTelligence ApS
GeneTelligence ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2016. The company has been dissolved on 9 December 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK 536,199 and a net result of DKK -1,886,251 compared with DKK -2,206,052 the year before. Equity in the 2023 report amounted to DKK -5,579,644.